Abstract
Effective treatment depends on the bioavailability of drugs, this feature related to the properties of permeability and solubility. The biopharmaceutical classification (SCB), based on these parameters, was proposed as a tool for the development of dosage forms, in order to assist in predicting the availability in vivo, since there are technical limitations, economic and ethical issues in…